Marker Therapeutics, Inc. (MRKR) › EPS (Diluted)Marker Therapeutics, Inc. (MRKR) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2015: $-9.302016: $-0.722017: $-1.162020: $-0.612021: $-5.472022: $-3.582023: $-0.942024: $-1.192025: $-0.79$-0.792015EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-0.79+33.6%2024$-1.19-26.6%2023$-0.94+73.7%2022$-3.58+34.6%2021$-5.47-796.7%2020$-0.61—2017$-1.16-61.1%2016$-0.72+92.3%2015$-9.30—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share